# Detemir: Role in Type 1 Diabetes

> **NCT00564395** · PHASE4 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 18 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Insulin Detemir mixed with RAI injection
- **DRUG:** Insulin Detemir and RAI injection

## Key facts

- **NCT ID:** NCT00564395
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08
- **Primary completion:** 2009-12
- **Final completion:** 2010-05
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00564395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00564395, "Detemir: Role in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00564395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*